Wed, June 14, 2023
Tue, June 13, 2023
Mon, June 12, 2023
Fri, June 9, 2023
Thu, June 8, 2023
Wed, June 7, 2023

Uy Ear Reiterated (ARQT) at Strong Buy and Held Target at $57 on, Jun 12th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-57-on-jun-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Uy Ear of Mizuho, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $57 on, Jun 12th, 2023.

Uy has made no other calls on ARQT in the last 4 months.



There are 5 other peers that have a rating on ARQT. Out of the 5 peers that are also analyzing ARQT, 0 agree with Uy's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Uy


  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $40 on, Friday, May 26th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $24 on, Wednesday, May 17th, 2023
  • Jonathan Block of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $33 on, Thursday, May 11th, 2023
  • Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $45 on, Wednesday, May 10th, 2023
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023

Publication Contributing Sources